Balancing Between Concentration and Volume when Developing Patient-Centric Biologics episode artwork

EPISODE · Aug 12, 2025 · 28 MIN

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

from PharmaTalkRadio · host Conference Forum

Summary:When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:Impact on increasing concentration of drugs on deliverabilityTechnical feasibility of manufacturing larger volume devicesPatient tolerability and human factors that impact patient adherenceThis panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.

Summary:When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:Impact on increasing concentration of drugs on deliverabilityTechnical feasibility of manufacturing larger volume devicesPatient tolerability and human factors that impact patient adherenceThis panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.

NOW PLAYING

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

0:00 28:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 28 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on August 12, 2025.

What is this episode about?

Summary:When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this PharmaTalkRadio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!